Top

Supportive Care in Cancer

Published in:

01-11-2009 | Review Article

Saliva substitutes for the treatment of radiation-induced xerostomia—a review

Authors: Sebastian Hahnel, Michael Behr, Gerhard Handel, Ralf Bürgers

Published in: Supportive Care in Cancer | Issue 11/2009

Abstract

Goal

The aim of this review is to summarize the in vitro and in vivo evidence on the performance of contemporary saliva substitutes in the treatment of xerostomia and hyposalivation caused by radiation therapy for head and neck malignancies.

Methods

A literature search was conducted during July to September 2008 in PubMed, using the query terms “saliva substitute”, “saliva substitute and xerostomia”, “artificial saliva”, and “artificial saliva and xerostomia”; for clinical studies, only studies in patients suffering from radiation-induced xerostomia have been included in the review.

Results and conclusion

Fifty-two studies met the inclusion criteria and were allotted either to the in vitro topics “viscosity”, “lubrication”, “wetting properties”, “antimicrobial effects”, and “enamel and dentin de- and remineralization”, or to the in vivo topics “clinical acceptance” or “influence on plaque formation and oral mucosa and microflora”. The findings suggest that there are significant differences in the performance of various saliva substitutes concerning the review parameters, yet indicate that further in vitro and in vivo studies on the properties of saliva substitutes are necessary.

Epstein JB, Stevenson-Moore P (1992) A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction. Spec Care Dentist 12:21–23. doi:10.1111/j.1754-4505.1992.tb00401.x CrossRefPubMed

Visch LL, S-Gravenmade EJ, Schaub RMH, van Putten WLJ, Vissink A (1986) A double-blind crossover trial of CMC- and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg 15:395–400PubMed

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12. doi:10.1016/0197-2456(95)00134-4 CrossRefPubMed

Hatton MN, Levine MJ, Margarone JE, Aguirre A (1987) Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofac Surg 45:496–499PubMedCrossRef

Mellema J, Holterman HJ, Waterman HA, Blom C, s-Gravenmade EJ (1992) Rheological aspects of mucin-containing solutions and saliva substitutes. Biorheology 29:231–249PubMed

Park MS, Chung JW, Kim YK, Chung SC, Kho HS (2007) Viscosity and wettability of animal mucin solutions and human saliva. Oral Dis 13:181–186. doi:10.1111/j.1601-0825.2006.01263.x CrossRefPubMed

Vissink A, Waterman HA, s-Gravenmade EJ, Panders AK, Vermey A (1984) Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide. J Oral Pathol 13:22–28. doi:10.1111/j.1600-0714.1984.tb01397.x CrossRefPubMed

Corcoran RA, Stovell AG, Urquhart D, Chui T, Richardson M (2006) Evaluation of a combined polymer system for use in relieving the symptoms of xerostomia. J Clin Dent 17:34–38PubMed

Van der Reijden WA, Veerman ECI, Amerongen AVN (1994) Rheological properties of commercially available polysaccharides with potential use in saliva substitutes. Biorheology 31:631–642PubMed

10.

Olsson H, Axéll T (1991) Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose. Scand J Dent Res 99:316–319PubMed

11.

Christersson CE, Lindh L, Arnebrant T (2000) Film-forming properties and viscosities of saliva substitutes and human whole saliva. Eur J Oral Sci 108:418–425. doi:10.1034/j.1600-0722.2000.108005418.x CrossRefPubMed

12.

Aguirre A, Mendoza B, Reddy MS, Scannapieco FA, Levine MJ, Hatton MN (1989) Lubrication of selected salivary molecules and artificial saliva. Dysphagia 4:95–100. doi:10.1007/BF02407152 CrossRefPubMed

13.

Vissink A, De Jong HP, Busscher HJ, Arends J, s-Gravenmade EJ (1986) Wetting properties of human saliva and saliva substitutes. J Dent Res 65:1121–1124PubMed

14.

Reeh ES, Douglas WH, Levine MJ (1996) Lubrication of saliva substitutes at enamel-to-enamel contacts in an artificial mouth. J Prosthet Dent 75:649–656. doi:10.1016/S0022-3913(96)90251-6 CrossRefPubMed

15.

Aydin AK, Terzioglu H, Ulubayram K, Hasirci N (1997) Wetting properties of saliva substitutes on acrylic resin. Int J Prosthodont 10:473–477PubMed

16.

Wolinsky LE, Seto B, Cerveny R (1985) Effect of saliva substitutes upon binding of selected oral bacteria to hydroxyapatite. Caries Res 19:507–511PubMed

17.

Hahnel S, Rosentritt M, Handel G, Bürgers R (2008) Influence of saliva substitute films on initial Streptococcus mutans adhesion to enamel and dental substrata. J Dent 36:977–983. doi:10.1016/j.jdent.2008.08.004 CrossRefPubMed

18.

Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Nishide S, Kono K et al (2008) Antimicrobial effects of the saliva substitute, Oralbalance®, against microorganisms from oral mucosa in the hematopoietic cell transplantation period. Support Care Cancer 16:421–424. doi:10.1007/s00520-007-0391-z CrossRefPubMed

19.

Ruissen ALA, Groenink J, Lommerse CH, Van’t Hof W, Veerman ECI, Amerongen AVN (2002) Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide. Arch Oral Biol 47:749–756. doi:10.1016/S0003-9969(02)00063-8 CrossRefPubMed

20.

Smith G, Smith AJ, Shaw L, Shaw MJ (2001) Artificial saliva substitutes and mineral dissolution. J Oral Rehabil 28:728–731. doi:10.1046/j.1365-2842.2001.00803.x CrossRefPubMed

21.

Kielbassa AM, Parichereh Shohadai S, Schulte-Mönting J (2000) Effect of saliva substitutes on mineral content of demineralized and sound dental enamel. Support Care Cancer 9:40–47. doi:10.1007/s005200000148 CrossRef

22.

Meyer-Lueckel H, Schulte-Mönting J, Kielbassa AM (2002) The effect of commercially available saliva substitutes on predemineralized bovine dentin in vitro. Oral Dis 8:192–198. doi:10.1034/j.1601-0825.2002.01762.x CrossRefPubMed

23.

Shannon IL, Trodahl JN, Starcke EN (1978) Remineralization of enamel by a saliva substitute designed for use by irradiated patients. Cancer 41:1746–1750. doi:10.1002/1097-0142(197805)41:5<1746::AID-CNCR2820410515>3.0.CO;2-C CrossRefPubMed

24.

Vissink A, s-Gravenmade EJ, Gelhard TBFM, Panders AK, Franken MH (1985) Rehardening properties of mucin- or CMC-containing saliva substitutes on softened human enamel. Caries Res 19:212–218PubMedCrossRef

25.

Joyston-Bechal S, Kidd EAM (1987) The effect of three commercially available saliva substitutes on enamel in vitro. Br Dent J 163:187–190. doi:10.1038/sj.bdj.4806238 CrossRefPubMed

26.

Van der Reijden WA, Buijs MJ, Damen JJM, Veerman ECI, ten Cate JM, Amerongen AV (1997) Influence of polymers for use in saliva substitutes on de- and remineralization of enamel in vitro. Caries Res 31:216–223PubMed

27.

Meyer-Lueckel H, Hopfenmuller W, von Klinggraf D, Kielbassa AM (2006) Microradiographic study on the effects of mucin-based solutions used as saliva substitutes on demineralised bovine enamel in vitro. Arch Oral Biol 51:541–547. doi:10.1016/j.archoralbio.2006.01.006 CrossRefPubMed

28.

Turssi CP, Lima RQV, Faraoni-Romano JJ, Serra MC (2006) Rehardening of caries-like lesions in root surfaces by saliva substitutes. Gerodontology 23:226–230. doi:10.1111/j.1741-2358.2006.00117.x CrossRefPubMed

29.

Gelhard TBFM, Fidler V, s-Gravenmade EJ, Vissink A (1983) Remineralization of softened human enamel in mucin- or CMC-containing artificial salivas. J Oral Pathol 12:336–341. doi:10.1111/j.1600-0714.1983.tb00345.x CrossRefPubMed

30.

Meyer-Lueckel H, Umland N, Hopfenmuller W, Kielbassa AM (2004) Effect of mucin alone and in combination with various dentifrices on in vitro remineralization. Caries Res 38:478–483. doi:10.1159/000079630 CrossRefPubMed

31.

Meyer-Lueckel H, Tschoppe P, Kielbassa AM (2006) Linseed based saliva substitutes and their effect on mineral dissolution of predemineralized bovine dentin in vitro. J Dent 34:750–756

32.

Meyer-Lueckel H, Tschoppe P, Hopfenmuller W, Stenzel WR, Kielbassa AM (2006) Effect of polymers used in saliva substitutes on demineralised bovine enamel and dentin. Am J Dent 19:308–312PubMed

33.

Meyer-Lueckel H, Chatzidakis AJ, Kielbassa AM (2007) Effect of various calcium/phosphates ratios of carboxymethylcellulose-based saliva substitutes on mineral loss of bovine enamel in vitro. J Dent 35:851–857. doi:10.1016/j.jdent.2007.08.006 CrossRefPubMed

34.

Shannon IL, McCrary BR, Starcke EN (1977) A saliva substitute for use by xerostomic patients undergoing radiotherapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 44:656–661

35.

Shannon IL, Edmonds EJ (1978) Effect of fluoride concentration on rehardening of enamel by a saliva substitute. Int Dent J 28:421–426PubMed

36.

Meyer-Lueckel H, Kielbassa AM (2006) Influence of calcium phosphates added to mucin-based saliva substitutes on bovine dentin. Quintessence Int 37:537–544

37.

Meyer-Lueckel H, Tschoppe P, Kielbassa AM (2006) Effect of various Ca²⁺/PO ₄ ³⁻ concentrations of linseed-based saliva substitutes on enamel in vitro. J Oral Rehabil 33:760–766. doi:10.1111/j.1365-2842.2006.01652.x CrossRefPubMed

38.

Tschoppe P, Meyer-Lueckel H, Kielbassa AM (2008) Effect of carboxymethylcellulose-based saliva substitutes on predemineralised dentin evaluated by microradiography. Arch Oral Biol 53:250–256. doi:10.1016/j.archoralbio.2007.10.001 CrossRefPubMed

39.

Ownby HE (1982) Use of a saliva substitute in postradiation xerostomic patients. Ky Dent J 34(19–20):22–24

40.

Nakamoto RY (1979) Use of a saliva substitute in postradiation xerostomia. J Prosthet Dent 42:539–542. doi:10.1016/0022-3913(79)90249-X CrossRefPubMed

41.

Jellema AP, Langendijk H, Bergenhenegouwen L, van der Reijden W, Leemans R, Smeele L et al (2001) The efficacy of Xialine® in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study. Radiother Oncol 59:157–160. doi:10.1016/S0167-8140(01)00336-X CrossRefPubMed

42.

Momm F, Volegova-Neher NJ, Schulte-Mönting J, Guttenberger R (2005) Different saliva substitutes for treatment of xerostomia following radiotherapy. Strahlenther Onkol 181:231–236. doi:10.1007/s00066-005-1333-7 CrossRefPubMed

43.

Walizer EM, Ephraim PM (1996) Double-blind cross-over controlled clinical trial of vegetable oil versus Xerolube for xerostomia: an expanded study abstract. ORL Head Neck Nurs 14:11–12PubMed

44.

Vissink A, s-Gravenmade EJ, Panders AK, Vermey A, Petersen JK, Visch LL et al (1983) A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg 12:232–238. doi:10.1016/S0300-9785(83)80048-9 CrossRefPubMed

45.

Johansson G, Andersson G, Attström R, Glantz PO, Larsson K (1994) The effect of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology 11:46–49. doi:10.1111/j.1741-2358.1994.tb00102.x CrossRefPubMed

46.

Andersson G, Johansson G, Attström R, Edwardsson S, Glantz PO, Larsson K (1995) Comparison of the effect of the linseed extract Salinum® and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 12:12–17. doi:10.1111/j.1741-2358.1995.tb00124.x CrossRefPubMed

47.

Regelink G, Vissink A, Reintsema H, Nauta JM (1998) Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 29:383–388PubMed

48.

Dirix P, Nuyts S, Poorten VV, Delaere P, van den Bogaert W (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer 15:1429–1436. doi:10.1007/s00520-006-0210-y CrossRefPubMed

49.

Warde P, Kroll B, O’Sullivan B, Aslanidis J, Tew-George E, Waldron J et al (2000) A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer 8:203–208. doi:10.1007/s005200050286 CrossRefPubMed

50.

Epstein JB, Emerton S, Le ND, Stevenson-Moore P (1999) A double-blind crossover trial of Oral Balance gel and Biotene® toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 35:132–137. doi:10.1016/S1368-8375(98)00109-2 CrossRefPubMed

51.

Nagy K, Urban E, Fazekas O, Thurzo L, Nagy E (2007) Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J Craniofac Surg 18:1157–1164CrossRefPubMed

52.

Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM (2005) A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl) 14:319–326. doi:10.1111/j.1365-2354.2005.00587.x CrossRef

53.

Johansson G, Andersson G, Attstöm R, Edwardsson S (2000) Oral mucous membrane flora in patients using saliva substitutes. Gerodontology 17:87–90. doi:10.1111/j.1741-2358.2000.00087.x CrossRefPubMed

Title: Saliva substitutes for the treatment of radiation-induced xerostomia—a review
Authors: Sebastian Hahnel
Michael Behr
Gerhard Handel
Ralf Bürgers
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 11/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-009-0671-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Goal

Methods

Results and conclusion

Please log in to get access to this content

Other articles of this Issue 11/2009

Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols

Determinants and implications of cancer patients’ psychosocial needs

Prevalence of depression among cancer patients in Jordan: a national survey

A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer

Routine assessment of social difficulties in cancer patients: are we opening Pandora’s box?

Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: a preliminary report

Keynote webinar | Spotlight on antibody–drug conjugates in cancer